Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.9550 (-11.25%) ($5.7700 - $6.5300) on Wed. Aug. 12, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.75% (three month average) | RSI | 57 | Latest Price | $5.9550(-11.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -6.4% a day on average for past five trading days. | Weekly Trend | CAPR declines -11.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IGOV(27%) BWX(18%) TLT(23%) CEMB(16%) VCIT(16%) | Factors Impacting CAPR price | CAPR will decline at least -4.375% in a week (0% probabilities). XLB(-30%) URA(-29%) PAVE(-27%) XOP(-24%) XLI(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.375% (StdDev 8.75%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $7.22 | 5 Day Moving Average | $6.63(-10.18%) | 10 Day Moving Average | $7.22(-17.52%) | 20 Day Moving Average | $7.22(-17.52%) | To recent high | -39.3% | To recent low | 18.9% | Market Cap | $117m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |